Table 3.
Predicted IOL power for studied formulas based on pre-dilation and post-dilation measurements for method A (lowest myopic spheroequivalent residual refraction, LMP) and actual IOL power for studied formulas based on pre-dilation and post-dilation measurements for method B (ideal power for emmetropia, IPE)
| IOL power formula | Mean ± SD | Mean difference | 95% CI for mean difference | p value | |
|---|---|---|---|---|---|
| Pre-dilation | Post-dilation | ||||
| Method A | |||||
| Barrett Universal II | 19.68 ± 3.63 | 19.80 ± 3.64 | 0.123 ± 0.238 | 0.076, 0.169 | < 0.001** |
| Olsen | 19.65 ± 3.62 | 19.79 ± 3.61 | 0.142 ± 0.257 | 0.092, 0.193 | < 0.001** |
| Hill-RBF | 19.77 ± 3.65 | 19.86 ± 3.64 | 0.088 ± 0.238 | 0.042, 0.135 | < 0.001** |
| Haigis | 19.88 ± 3.71 | 19.99 ± 3.70 | 0.108 ± 0.250 | 0.059, 0.157 | < 0.001** |
| Holladay I | 19.80 ± 3.78 | 19.81 ± 3.77 | 0.010 ± 0.244 | − 0.038, 0.058 | 0.26 |
| SRK/T | 19.78 ± 3.65 | 19.77 ± 3.63 | − 0.010 ± 0.233 | − 0.056, 0.036 | 0.81 |
| Method B | |||||
| Barrett Universal II | 19.40 ± 3.58 | 19.43 ± 3.57 | 0.030 ± 0.215 | − 0.013, 0.073 | 0.16 |
| Olsen | 19.39 ± 3.54 | 19.47 ± 3.53 | 0.076 ± 0.233 | 0.030, 0.123 | 0.002 |
| Hill-RBF | 19.49 ± 3.58 | 19.52 ± 3.58 | 0.021 ± 0.216 | − 0.022, 0.064 | 0.35 |
| Haigis | 19.56 ± 3.63 | 19.61 ± 3.66 | 0.055 ± 0.259 | 0.003, 0.107 | 0.04 |
| Holladay I | 19.57 ± 3.74 | 19.57 ± 3.74 | 0.005 ± 0.213 | − 0.038, 0.047 | 0.82 |
| SRK/T | 19.44 ± 3.57 | 19.45 ± 3.57 | 0.002 ± 0.189 | − 0.035, 0.040 | 0.89 |
**p value confirmed with Wilcoxon signed-rank test